LD-2 disclosure · 4th Quarter - Termination
TRIUS THERAPEUTICS
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Pharmaceutical Development
- Location
- California · United States of America
Registrant
- Description
- Global trade
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Antibiotics, BioDefense
Lobbyistsms WENDY SHELTON dvm
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD) · Health & Human Services, Dept of (HHS) · Natl Institutes of Health (NIH)